Skip to main content
Novel, Fractionated Dosing Formulations for
Optimizing Titration of Carbidopa/Levodopa
A Practical Roadmap for Improving Patient Satisfaction, Motor Symptoms, Clinical Outcomes, and ON/OFF Time in Persons with PD
LEARN MORE >
The Role, Rationale, Evidence and Practical Application of
Combination Therapy with DTE in Selected Patients with Hypothyroidism
A Year 2021 Hypothyroidism Update for the Endocrinology, Primary Care, Internal Medicine, and Thyroid Specialist
LEARN MORE >
Critical Advances in Mitigating Progression of Diabetic Eye Disease
The Role of Screening, Prompt Referral, and Ant-VEGF Therapy to Prevent Vision Loss Association with DR, DME and AMD
LEARN MORE >
Glucose Monitoring in the Managed Care Pharmacy and Medical Setting
Real-World Data Supporting CGM Across the Diabetes Spectrum
LEARN MORE >
Interpreting Sensor-Based Glucose Metrics, Time in Range and Ambulatory Glucose Profiles (AGP)
Optimizing eA1c and the Glucose Management Indicator (GMI) in Persons with Diabetes Requiring and Not Requiring Insulin Therapy
A Three-Module Virtual Symposium
LEARN MORE >
Evidence, Guidelines, Mechanisms, and Trials Supporting Biologics-Based
Targeting of Type 2 Cytokine Signaling Proteins for Moderate-to-Severe AD in
Children, Adolescents and Adults A Year 2020 Clinical Practice Roadmap for the Pediatric and Adult Dermatology Specialist, Clinical Immunologist, Adolescent Physician, Allergist, Pediatrician and Related Specialists LEARN MORE >
Importance of Early Diagnosis, Testing, and Recognition of Unusual and Heterogeneous Symptoms and Hallmarks of

Fabry Disease Across Multiple Clinical Specialties A Year 2020 Diagnostic, Assessment, and Fabry Disease Management Update for the GI, Neurological, Renal, CV, Dermatologic and Clinical Genetics Specialist LEARN MORE >
Therapeutic Advances, Novel Formulations and Patient Adherence for Optimizing Management of
MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE
Focus on the Safety, Evidence and Rationale for Inhaled Antimicrobial Suspension
LEARN MORE >
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction Focus on Trial-Based Evidence for PCSK9-Mediated LDL-C Lowering to Optimize Treatment and Prevention of ASCVD LEARN MORE >

    iQ&A interactive Medical Intelligence Zone welcomes your questions and your participation in the iQ&A community.

FEATURED MASTER CURRICULUM-BASED LEARNING AND CME (MCL-CME) SERIES

Featured Specialties

Cardiology
Diabetes
Diagnostic Medicine
Mac Lung Disease
Cancer
Primary Care
Dermatology
Biologics
Arthritis

    iQ&A (interactive Medical Intelligence) welcomes your questions and your participation in the iQ&A community.

pre